Chien-Yu Lu
Overview
Explore the profile of Chien-Yu Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang W, Liao S, Huang H, Tsai P, Huang H, Lu C, et al.
Health Econ Rev
. 2024 Sep;
14(1):71.
PMID: 39235715
Introduction: This study comprehensively investigates the changes in healthcare utilization among chronic patients with regular outpatient visits to hospitals after the occurrence of Covid-19. The research examines whether patients altered...
2.
Huang W, Liao S, Huang H, Su Y, Jerng J, Lu C, et al.
Sci Rep
. 2024 Jun;
14(1):14626.
PMID: 38918486
Under Taiwan's National Health Insurance (NHI) system, it's crucial for all healthcare providers to accurately submit medical expense claims to the National Health Insurance Administration (NHIA) to avoid incorrect deductions....
3.
Lin W, Tai W, Chang C, Tu C, Feng I, Shieh M, et al.
Inflamm Bowel Dis
. 2023 Jan;
29(11):1730-1740.
PMID: 36626567
Background: This nationwide prospective registry study investigated the real-world effectiveness, safety, and persistence of vedolizumab (VDZ) in inflammatory bowel disease (IBD) patients in Taiwan. Disease relapse rates after VDZ discontinuation...
4.
Lepczynska M, Dzika E, Chen W, Lu C
Clin Transl Gastroenterol
. 2021 Apr;
12(4):e00325.
PMID: 33835078
Introduction: Proton pump inhibitors (PPIs) and histamine receptor 2 (H2) antagonists are commonly prescribed medications. Association between PPIs and alteration of the gut microbiota has been reported. Blastocystis, the most...
5.
Yeh Y, Chen Y, Tsai H, Huang C, Ma C, Su W, et al.
Pathol Oncol Res
. 2019 May;
26(2):1105-1116.
PMID: 31077069
The dismal outcome in patients with locally advanced or metastatic gastric cancer (GC) highlights the need for effective systemic neoadjuvant chemotherapy to improve clinical results. This study evaluated the correlation...
6.
Hsieh M, Liu C, Hsu W, Li C, Tsai P, Hu H, et al.
Helicobacter
. 2019 Mar;
24(2):e12568.
PMID: 30821043
Background: Culture of Helicobacter pylori with previous eradication failure has been emphasized in clinical guidelines. The current unmet need to manage previously treated H pylori is one tool with diagnostic...
7.
Wang K, Chen Y, Wang T, Hsu W, Wu I, Yu F, et al.
J Gastroenterol Hepatol
. 2018 Dec;
34(5):837-842.
PMID: 30550642
Background And Aim: Asian populations have relatively lower prevalence of gastroesophageal reflux disease and tend to exhibit symptoms of prolonged gastric retention. However, it remains unknown if slower gastric emptying...
8.
Chen C, Lin Y, Tsai H, Huang C, Yeh Y, Ma C, et al.
J Minim Access Surg
. 2018 Feb;
14(4):321-334.
PMID: 29483373
Background: Three operative techniques have been used for colorectal cancer (CRC) resection: Conventional laparotomy (CL) and the mini-invasive techniques (MITs)- laparoscopic-assisted surgery (LAS) and mini-laparotomy (ML). The aim of the...
9.
Chuang Y, Wu M, Yu F, Wang Y, Lu C, Wu D, et al.
Oncotarget
. 2017 Nov;
8(44):78011-78022.
PMID: 29100443
Cigarette smoking is a well-known risk factor of upper digestive diseases. Findings on alcohol's effect on these diseases are inconsistent and with the exception of its association with esophageal cancer,...
10.
Huang C, Yeh Y, Ma C, Tsai H, Chen C, Huang M, et al.
Chemotherapy
. 2016 Sep;
62(1):80-84.
PMID: 27654129
Metastatic colorectal cancer (mCRC) combined with hyperbilirubinemia is typically considered a contraindication to irinotecan-based therapy, a proven first-line treatment of mCRC. Herein, we present 6 consecutive patients with mCRC combined...